Hussman Strategic Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,000
| Closed | -$225K | – | 306 |
|
|
2023
Q1 | $225K | Hold |
31,000
| – | – | 0.04% | 293 |
|
|
2022
Q4 | $275K | Buy |
31,000
+20,600
| +198% | +$183K | 0.04% | 276 |
|
|
2022
Q3 | $127K | Hold |
10,400
| – | – | 0.02% | 277 |
|
|
2022
Q2 | $123K | Hold |
10,400
| – | – | 0.02% | 295 |
|
|
2022
Q1 | $198K | Hold |
10,400
| – | – | 0.04% | 292 |
|
|
2021
Q4 | $276K | Sell |
10,400
-8,200
| -44% | -$218K | 0.06% | 284 |
|
|
2021
Q3 | $764K | Sell |
18,600
-12,400
| -40% | -$509K | 0.17% | 190 |
|
|
2021
Q2 | $1.76M | Buy |
31,000
+16,600
| +115% | +$940K | 0.36% | 106 |
|
|
2021
Q1 | $605K | Sell |
14,400
-16,350
| -53% | -$687K | 0.12% | 238 |
|
|
2020
Q4 | $2.16M | Sell |
30,750
-45,750
| -60% | -$3.21M | 0.57% | 62 |
|
|
2020
Q3 | $2.15M | Sell |
76,500
-25,500
| -25% | -$716K | 0.57% | 56 |
|
|
2020
Q2 | $3.02M | Sell |
102,000
-500
| -0.5% | -$14.8K | 0.77% | 15 |
|
|
2020
Q1 | $2.03M | Buy |
102,500
+36,000
| +54% | +$714K | 0.55% | 54 |
|
|
2019
Q4 | $1.97M | Buy |
+66,500
| New | +$1.97M | 0.63% | 57 |
|